Risks of packed red blood cell transfusion in patients undergoing cardiac surgery

Journal of Critical Care

Volumn 27, Issue 6, 2012, Pages 737.e1-737.e9

  Gerber, David R ^a,b,c  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^b Cooper Medical School of Rowan University ^*  (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Anemia; Blood transfusion; Cardiac surgery; Complications

Indexed keywords

HEMOGLOBIN;

ADVERSE OUTCOME; ALTERNATIVE MEDICINE; ANEMIA; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY BYPASS GRAFT; DISEASE ACTIVITY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART SURGERY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LUNG COMPLICATION; LUNG DISEASE; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL MORTALITY; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT INDICATION;

EID: 84870653190     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.05.007     Document Type: Review

References (70)

1. Daly D.J., Myles P.S., Smith J.A., et al. Anticoagulation, bleeding and blood transfusion practices in Australasian cardiac surgical practice. Anaesth Intensive Care 2007, 35(5):760-768. ANZCA Trials Group.
2. Andreasen J.J., Westen M., Pallesen P.A., et al. Transfusion practice in coronary artery bypass surgery in Denmark: a multicenter audit. Interact Cardiovasc Thorac Surg 2007, 6(5):623-627.
3. Schiferer A., Panzer S., Reesink H.W., et al. Red cell transfusion in elective cardiac surgery patients. Vox Sang 2009, 97(2):172-182.
4. Ferraris V.A., Ferraris S.P., Saha S.P., Spiess B.D., Shore-Lesserson L., Stafford-Smith M., et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007, 83(5 Suppl):S27-S86. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Society of Cardiovascular Anesthesiologists Special Task Force on Blood TransfusionSociety of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion.
5. Ferraris V.A., Brown J.R., Despotis G.J., Shore-Lesserson L.J., Goodnough L.T., Mazer C.D., Dickinson T.A., FitzGerald D.J., Likosky D.S., et al. 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. Ann Thorac Surg 2011, 91:944-982. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Society of Cardiovascular Anesthesiologists Special Task Force on Blood TransfusionSociety of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion, International Consortium for Evidence Based PerfusionInternational Consortium for Evidence Based Perfusion.
6. Gould S., Cimino M.J., Gerber D.R. Packed red blood cell transfusion in the intensive care unit: limitations and consequences. Am J Crit Care 2007, 16(1):39-48.
7. Napolitano L.M., Kurek S., Luchette F.A., et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009, 37(12):3124-3157. American College of Critical Care Medicine of the Society of Critical Care Medicine; Eastern Association for the Surgery of Trauma Practice Management Workgroup.
8. Sihler K.C., Napolitano L.M. Complications of massive transfusion. Chest 2010, 137(1):209-220.
9. Zeidman A., Fradin Z., Blecher A., et al. Anemia as a risk factor for ischemic heart disease. Isr Med Assoc J 2004, 6(1):16-18.
10. Cavusoglu E., Chopra V., Gupta A., et al. Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome. Am J Cardiol 2006, 98(5):580-584.
11. Sabatine M.S., Morrow D.A., Giugliano R.P., et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005, 111(16):2042-2049.
12. Bracey A.W., Radovancevic R., Riggs S.A., et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 1999, 39(10):1070-1077.
13. Klass O., Mehlhorn U., Zilkens K., et al. Impact of hematocrit value after coronary artery surgery on perioperative myocardial infarction rate. Thorac Cardiovasc Surg 2002, 50(5):259-265.
14. Senay S., Toraman F., Karabulut H., et al. Is it the patient or the physician who cannot tolerate anemia? A prospective analysis in 1854 non-transfused coronary artery surgery patients. Perfusion 2009, 24(6):373-380.
15. Carrascal Y., Maroto L., Rey J., et al. Impact of preoperative anemia on cardiac surgery in octogenarians. Interact Cardiovasc Thorac Surg 2010, 10(2):249-255.
16. Weiskopf R.B., Viele M.K., Feiner J., et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998 Jan 21, 279(3):217-221.
17. Van der Linden P. Acute normovolemic anemia: physiologic and practical concerns. Jurnalul de Chirurgie. 2007, 3(3):230-237.
18. Kor D.J., Van Buskirk C.M., Gajic O. Red blood cell storage lesion. Bosn J Basic Med Sci 2009, 9(Suppl. 1):21-27.
19. Whitaker B.I., Sullivan M. The 2005 Nationwide Blood Collection and Utilization Survey Report Available on line at:, Accessed June 13, 2010. http://aabb.org/apps/docs/05nbcusrpt.pdf.
20. van de Watering L., Lorinser J., Versteegh M., et al. Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion 2006, 46(10):1712-1718.
21. Yap C.H., Lau L., Krishnaswamy M., et al. Age of transfused red cells and early outcomes after cardiac surgery. Ann Thorac Surg 2008, 86(2):554-559.
22. Koch C.G., Li L., Sessler D.I., Figueroa P., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008, 358(12):1229-1239.
23. Andreasen J.J., Dethlefsen C., Modrau I.S., et al. Storage time of allogeneic red blood cells is associated with risk of severe postoperative infection after coronary artery bypass grafting. Eur J Cardiothorac Surg 2011, 39(3):329-334.
24. McKenny M., Ryan T., Tate H., et al. Age of transfused blood is not associated with increased postoperative adverse outcome after cardiac surgery. Br J Anaesth 2011, 106(5):643-649.
25. Engoren M.C., Habib R.H., Zacharias A., et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002, 74(4):1180-1186.
26. Kuduvalli M., Oo A.Y., Newall N., et al. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg 2005, 27(4):592-598.
27. Koch C.G., Li L., Duncan A.I., et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006, 81(5):1650-1657.
28. Surgenor S.D., Kramer R.S., Olmstead E.M., et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 2009, 108(6):1741-1746. Northern New England Cardiovascular Disease Study Group.
29. Engoren M., Habib R.H., Hadaway J., et al. The effect on long-term survival of erythrocyte transfusion given for cardiac valve operations. Ann Thorac Surg 2009, 88(1):95-100.
30. van Straten A.H., Bekker M.W., Soliman Hamad M.A., et al. Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up. Interact Cardiovasc Thorac Surg 2010, 10(1):37-42.
31. Weightman W.M., Gibbs N.M., Sheminant M.R., et al. Moderate exposure to allogeneic blood products is not associated with reduced long-term survival after surgery for coronary artery disease. Anesthesiology 2009, 111(2):327-333.
32. Ranucci M., Pazzaglia A., Bianchini C., et al. Body size, gender, and transfusions as determinants of outcome after coronary operations. Ann Thorac Surg 2008, 85(2):481-486.
33. Veenith T., Sharples L., Gerrard C., et al. Survival and length of stay following blood transfusion in octogenarians following cardiac surgery. Anaesthesia 2010, 65(4):331-336.
34. Hajjar L.A., Vincent J.L., Galas F.R., et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010, 304(14):1559-1567.
35. Vamvakas E.C., Blajchman M.A. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009, 113(15):3406-3417.
36. Sood N., Coleman C.I., Kluger J., et al. The association among blood transfusions, white blood cell count, and the frequency of post-cardiothoracic surgery atrial fibrillation: a nested cohort study from the Atrial Fibrillation Suppression Trials I, II, and III. J Cardiothorac Vasc Anesth 2009, 23(1):22-27.
37. Choi Y.S., Shim J.K., Hong S.W., et al. Risk factors of atrial fibrillation following off-pump coronary artery bypass graft surgery: predictive value of C-reactive protein and transfusion requirement. Eur J Cardiothorac Surg 2009, 36(5):838-843.
38. Anderson J.L., Allen Maycock C.A., Lappé D.L., et al. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol 2004, 94(10):1255-1259. Intermountain Heart Collaborative Study group.
39. Aviles R.J., Martin D.O., Apperson-Hansen C., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003, 108(24):3006-3010.
40. Fransen E., Maessen J., Dentener M., et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999, 116(5):1233-1239.
41. Spiess B.D., Ley C., Body S.C., et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1998, 116(3):460-467. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
42. Surgenor S.D., DeFoe G.R., Fillinger M.P., et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 2006, 114(1 Suppl):I43-I148.
43. Roback J.D., Neuman R.B., Quyyumi A., et al. Insufficient nitric oxide bioavailability: a hypothesis to explain adverse effects of red blood cell transfusion. Transfusion 2011, 51(4):859-866.
44. Roback J.D. Vascular effects of the red blood cell storage lesion. Hematology Am Soc Hematol Educ Program. 2011, 2011:475-479.
45. Skeate R.C., Eastlund T. Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Curr Opin Hematol 2007, 14(6):682-687.
46. Popovsky M.A. Pulmonary consequences of transfusion: TRALI and TACO. Transfus Apher Sci 2006, 34(3):243-244.
47. Vamvakas E.C., Carven J.H. Allogeneic blood transfusion and postoperative duration of mechanical ventilation: effects of red cell supernatant, platelet supernatant, plasma components and total transfused fluid. Vox Sang 2002, 82(3):141-149.
48. Koch C.G., Li L., Duncan A.I., et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006, 34(6):1608-1616.
49. Cislaghi F., Condemi A.M., Corona A. Predictors of prolonged mechanical ventilation in a cohort of 5123 cardiac surgical patients. Eur J Anaesthesiol 2009, 26(5):396-403.
50. Koch C., Li L., Figueroa P., Mihaljevic T., et al. Transfusion and pulmonary morbidity after cardiac surgery. Ann Thorac Surg 2009, 88(5):1410-1418.
51. Ali Z.A., Lim E., Motalleb-Zadeh R., et al. Allogenic blood transfusion does not predispose to infection after cardiac surgery. Ann Thorac Surg 2004, 78(5):1542-1546.
52. Chelemer S.B., Prato B.S., Cox P.M., et al. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 2002, 73(1):138-142.
53. Leal-Noval S.R., Rincón-Ferrari M.D., García-Curiel A., et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001, 119(5):1461-1468.
54. Sreeram G.M., Welsby I.J., Sharma A.D., et al. Infectious complications after cardiac surgery: lack of association with fresh frozen plasma or platelet transfusions. J Cardiothorac Vasc Anesth 2005, 19(4):430-434.
55. Banbury M.K., Brizzio M.E., Rajeswaran J., et al. Transfusion increases the risk of postoperative infection after cardiovascular surgery. J Am Coll Surg 2006, 202(1):131-138.
56. Crabtree T., Aitchison D., Meyers B.F., et al. Clostridium difficile in cardiac surgery: risk factors and impact on postoperative outcome. Ann Thorac Surg 2007, 83(4):1396-1402.
57. Rogers M.A., Blumberg N., Saint S., et al. Hospital variation in transfusion and infection after cardiac surgery: a cohort study. BMC Med 2009, 31(7):37. 10.1186/1741-7015-7-37.
58. Sharma A.D., Slaughter T.F., Clements F.M., et al. Association of leukocyte-depleted blood transfusions with infectious complications after cardiac surgery. Surg Infect (Larchmt) 2002, 3(2):127-133.
59. Vamvakas E.C., Blajchman M.A. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007, 21(6):327-348.
60. Blajchman M.A. Immunomodulation and blood transfusion. Am J Ther 2002, 9(5):389-395.
61. Habib R.H., Zacharias A., Schwann T.A., et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome. Crit Care Med 2005, 33(8):1749-1756.
62. Huybregts R.A., de Vroege R., Jansen E.K., et al. The association of hemodilution and transfusion of red blood cells with biochemical markers of splanchnic and renal injury during cardiopulmonary bypass. Anesth Analg 2009, 109(2):331-339.
63. Karkouti K., Wijeysundera D.N., Yau T.M., et al. Influence of erythrocyte transfusion on the risk of acute kidney injury after cardiac surgery differs in anemic and nonanemic patients. Anesthesiology 2011 Sep, 115(3):523-530.
64. Alfirevic A., Meng Xu M., Johnston D. Transfusion increases the risk for vasoplegia after cardiac operations. Ann Thorac Surg 2011, 92:812-819.
65. Vymazal T., Horácek M., Durpekt R., et al. Is allogeneic blood transfusion a risk factor for sternal dehiscence following cardiac surgery? A prospective observational study. Int Heart J 2009, 50(5):601-607.
66. Brevig J., McDonald J., Zelinka E.S., et al. Blood transfusion reduction in cardiac surgery: multidisciplinary approach at a community hospital. Ann Thorac Surg 2009, 87(2):532-539.
67. Ela Y., Emmiler M., Kocogullari C.U., et al. Advantages of autologous blood transfusion in off-pump coronary artery bypass. Heart Surg Forum 2009, 12(5):E261-E265.
68. Weltert L., D'Alessandro S., Nardella S., et al. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg 2010, 139(3):621-626.
69. Alghamdi A.A., Albanna M.J., Guru V., et al. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg 2006, 21(3):320-326.
70. Najjar S.S., Rao S.V., Melloni C., et al. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA 2011, 305(18):1863-1872.